Our Studies
Inner Space Research is currently enrolling patients in clinical trials for the following:
Depression – Cybin 003-002
For adults with a diagnosis of Major Depressive Disorder (MDD) currently experiencing a Major Depressive Episode (MDE).
The goal of this study is to evaluate the efficacy, safety, and tolerability of CYB003, compared to placebo, in treating symptoms of MDD in adult participants.
This study is sponsored by Cybin.
Depression – J&J MDD3014
For adults with a diagnosis of Major Depressive Disorder (MDD) who continue to experience symptoms despite being on an antidepressant medication.
The goal of this study is to evaluate the efficacy, safety, and tolerability of ABX-002, an oral thyroid hormone receptor-beta (TRβ) agonist, as an adjunctive treatment for MDD. Participants will receive either ABX-002 or placebo in addition to their current antidepressant for approximately six weeks.
This study is sponsored by Autobahn Therapeutics, Inc.
Depression – Autobahn ABX-002-MDD-2001
For adults with a diagnosis of Major Depressive Disorder (MDD) who continue to experience symptoms despite being on an antidepressant medication.
The goal of this study is to evaluate the efficacy, safety, and tolerability of ABX-002, an oral thyroid hormone receptor-beta (TRβ) agonist, as an adjunctive treatment for MDD. Participants will receive either ABX-002 or placebo in addition to their current antidepressant for approximately six weeks.
This study is sponsored by Autobahn Therapeutics, Inc.